This study also revealed an additional cancer relevant scenario—while β-arrestin 1 signaling downstream of IGF-1R acts to inhibit p53, removal of this through β-arrestin 2 allows for p53 accumulation (89, 90). The gene discussed is TP53; the disease is cancer.